Enhanced Out-of-plane Emission of K+ Mesons observed in Au+Au Collisions at 1 AGeV

The azimuthal angular distribution of K+ mesons has been measured in Au + Au collisions at 1 AGeV. In peripheral and semi-central collisions, K+ mesons preferentially are emitted perpendicular to the reaction plane. The strength of the azimuthal anisotropy of K+ emission is comparable to the one of pions. No in-plane flow was found for K+ mesons near projectile and target rapidity.Comment: Accepted for publication in Phys. Rev.Let

Evidence for a Soft Nuclear Equation-of-State from Kaon Production in Heavy Ion Collisions

The production of pions and kaons has been measured in Au+Au collisions at beam energies from 0.6 to 1.5 AGeV with the Kaon Spectrometer at SIS/GSI. The K+ meson multiplicity per nucleon is enhanced in Au+Au collisions by factors up to 6 relative to C+C reactions whereas the corresponding pion ratio is reduced. The ratio of the K+ meson excitation functions for Au+Au and C+C collisions increases with decreasing beam energy. This behavior is expected for a soft nuclear equation-of-state.Comment: 14 pages, 2 figures, accepted for publication in Phys. Rev. Let

Kaon and Antikaon Production in Heavy Ion Collisions at 1.5 AGeV

At the Kaon Spectrometer KaoS at SIS, GSI the production of kaons and antikaons in heavy ion reactions at a beam energy of 1.5 AGeV has been measured for the collision systems Ni+Ni and Au+Au. The K-/K+ ratio is found to be constant for both systems and as a function of impact parameter but the slopes of K+ and K- spectra differ for all impact parameters. Furthermore the respective polar angle distributions will be presented as a function of centrality.Comment: 4 pages, 4 figures, SQM2001 in Frankfurt, Sept.2001, submitted to Journal of Physics

Production of Charged Pions, Kaons and Antikaons in Relativistic C+C and C+Au Collisions

Production cross sections of charged pions, kaons and antikaons have been measured in C+C and C+Au collisions at beam energies of 1.0 and 1.8 AGeV for different polar emission angles. The kaon and antikaon energy spectra can be described by Boltzmann distributions whereas the pion spectra exhibit an additional enhancement at low energies. The pion multiplicity per participating nucleon M(pi+)/A_part is a factor of about 3 smaller in C+Au than in C+C collisions at 1.0 AGeV whereas it differs only little for the C and the Au target at a beam energy of 1.8 AGeV. The K+ multiplicities per participating nucleon M(K+)/A_part are independent of the target size at 1 AGeV and at 1.8 AGeV. The K- multiplicity per participating nucleon M(K-)/A_part is reduced by a factor of about 2 in C+Au as compared to C+C collisions at 1.8 AGeV. This effect might be caused by the absorption of antikaons in the heavy target nucleus. Transport model calculations underestimate the K-/K+ ratio for C+C collisions at 1.8 AGeV by a factor of about 4 if in-medium modifications of K mesons are neglected.Comment: 19 pages, 14 figures, accepted for publication in Eur. Phys. J.

Low-energy cross section of the 7Be(p,g)8B solar fusion reaction from Coulomb dissociation of 8B

Final results from an exclusive measurement of the Coulomb breakup of 8B into 7Be+p at 254 A MeV are reported. Energy-differential Coulomb-breakup cross sections are analyzed using a potential model of 8B and first-order perturbation theory. The deduced astrophysical S_17 factors are in good agreement with the most recent direct 7Be(p,gamma)8B measurements and follow closely the energy dependence predicted by the cluster-model description of 8B by Descouvemont. We extract a zero-energy S_17 factor of 20.6 +- 0.8 (stat) +- 1.2 (syst) eV b.Comment: 14 pages including 16 figures, LaTeX, accepted for publication in Physical Review C. Minor changes in text and layou

A Measurement of the Coulomb Dissociation of 8B at 254 MeV/nucleon and the 8B Solar Neutrino Flux

We have measured the Coulomb dissociation of 8B into 7Be and proton at 254 MeV/nucleon using a large-acceptance focusing spectrometer. The astrophysical S17 factor for the 7Be(p,gamma)8B reaction at E{c.m.} = 0.25-2.78 MeV is deduced yielding S17(0)=20.6 \pm 1.2 (exp.) \pm 1.0 (theo.) eV-b. This result agrees with the presently adopted zero-energy S17 factor obtained in direct-reaction measurements and with the results of other Coulomb-dissociation studies performed at 46.5 and 51.2 MeV/nucleon.Comment: paper to be published in Phys. Rev. Lett. 3 figures. New Version fixes formatting problems with the figures only. There are no other change

A magic pill? A qualitative analysis of patients' views on the role of antidepressant therapy in inflammatory bowel disease (IBD)

Background: Studies with healthy volunteers have demonstrated that antidepressants can improve immunoregulatory activity and thus they may have a potential to positively impact the disease course in inflammatory bowel disease (IBD), a chronic and incurable condition. However, patients’ views on the role of antidepressants in the management of their IBD are unknown. Thus, this study aimed to explore patients’ experiences and opinions regarding the effect of antidepressants on IBD course before possibly undertaking future treatment trials with antidepressants. Methods: Semi-structured in-depth interviews with open-ended questions were conducted with a randomly selected sample of IBD patients recruited at the Australian public hospital IBD clinic and currently receiving antidepressants. A qualitative content analysis was undertaken to summarise patients’ responses. A Visual Analogue Scale was used to provide a quantitative assessment of patients’ experiences with antidepressants. Results: Overall, 15 IBD sufferers currently on antidepressants (nine females, six males) were interviewed. All 15 reported a positive response to antidepressants reporting they improved their quality of life, with minimal sideeffects. Five patients (33.3%) felt the antidepressant had specifically improved their IBD course. Three patients noted how they believed the reduction in feelings of stress mediated the positive influence of the antidepressant on IBD course. Ten patients (66.7%) felt the antidepressants had not specifically influenced their IBD. Nine patients (60.0%) had a generally positive attitude towards antidepressants, four patients (26.7%) were ambivalent, and two patients (13.3%) held a negative view towards antidepressants. Twelve patients (80.0%) stated that they would be willing to participate in clinical trials. Conclusions: Antidepressants seem to be well tolerated by IBD patients. One third of patients reported an observable improvement of their IBD under the influence of this treatment. The positive attitude towards antidepressants in these participants may make the conduct of clinical trials to further assess for any specific role on IBD course feasible. However, due to a small sample size, a qualitative nature of this study and in light of the results of studies on other populations indicating reluctance to taking antidepressants at least in some patients, these results should be interpreted with caution until confirmed in quantitative studies.Antonina A Mikocka-Walus, Andrea L Gordon, Benjamin J Stewart and Jane M Andrew